IDERA PHARMACEUTICALS, INC. (55) | Change of Control Agreements (2)
- Severance and Change of Control Agreement, dated February 19, 2021, by and between the Company and Daniel Soland (Filed With SEC on March 1, 2021)
- Amendment to Severance and Change of Control Agreement, dated January 27, 2020, by and between the Company and Dr. Jonathan Yingling (Filed With SEC on January 27, 2020)
